Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing.

MLA

Hou, Yujuan, et al. “Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing.” Genes, vol. 13, no. 12, Dec. 2022. EBSCOhost, https://doi.org/10.3390/genes13122348.

APA

Hou, Y., Ureña-Bailén, G., Mohammadian Gol, T., Gratz, P. G., Gratz, H. P., Roig-Merino, A., Antony, J. S., Lamsfus-Calle, A., Daniel-Moreno, A., Handgretinger, R., & Mezger, M. (2022). Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing. Genes, 13(12). https://doi.org/10.3390/genes13122348

Chicago

Hou, Yujuan, Guillermo Ureña-Bailén, Tahereh Mohammadian Gol, Paul Gerhard Gratz, Hans Peter Gratz, Alicia Roig-Merino, Justin S Antony, et al. 2022. “Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing.” Genes 13 (12). doi:10.3390/genes13122348.